Rosuvastatin versus atorvastatin following PCI in patients also receiving clopidogrel

Trial Profile

Rosuvastatin versus atorvastatin following PCI in patients also receiving clopidogrel

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Mar 2011

At a glance

  • Drugs Clopidogrel (Primary) ; Atorvastatin; Rosuvastatin
  • Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 08 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top